The much-awaited Aequs Limited Initial Public Offering (IPO) has reached a key milestone with the finalization of its allotment on December 8, 2025. Following an overwhelming response from investors across categories, the company is now set to make its debut on the stock exchanges. With shares being credited to successful applicants today, December 9, and listing scheduled for December 10 on both BSE and NSE, anticipation is running high about how the stock will perform on its first day of trading.
Subscription Performance
The IPO was priced in the band of ₹118–₹124 per share, with a total issue size of ₹921.81 crore. This included a fresh issue worth ₹670 crore and an offer for sale of ₹251.81 crore. Investor enthusiasm was evident in the oversubscription levels:
- Qualified Institutional Buyers (QIBs): 120.92 times.
- Non-Institutional Investors (NIIs): 80.59 times.
- Retail Investors: 77.47 times.
Overall, the IPO was oversubscribed 104.30 times, making it one of the most successful offerings of the year.
Allotment and Refunds
The basis of allotment was finalized on December 8, and shares are being credited to demat accounts today, December 9. Refunds for those who did not secure allotment are also being processed.
Investors can check their allotment status through:
- NSE portal (Equity & SME IPO bid details).
- BSE portal (Investor Services → Status of Issue Application).
- Registrar Kfin Technologies website.
Grey Market Premium (GMP) Trends
The IPO has generated strong activity in the grey market, with a premium of around ₹34 per share. This points to a potential listing price of ₹158, which is nearly 28% higher than the upper price band. Analysts believe this premium reflects investor optimism about Aequs’ prospects, though GMP levels have shown slight fluctuations in recent days.
Company Profile
Aequs Limited is a global contract manufacturing company specializing in consumer durable goods and aerospace components. With operations spanning multiple geographies, the company has positioned itself as a key player in India’s manufacturing ecosystem. Its diversified portfolio and strong industry linkages have made it an attractive bet for investors seeking exposure to India’s industrial growth story.
Risks and Considerations
While the IPO’s oversubscription and GMP trends suggest a strong debut, investors should remain mindful of:
- Market volatility: Listing gains may vary depending on broader market sentiment.
- Sectoral competition: Contract manufacturing is highly competitive, which could pressure margins.
- Global demand cycles: Aerospace and consumer durable demand trends will influence long-term growth.
The Aequs IPO allotment marks a pivotal step in the company’s public journey, with listing scheduled for December 10, 2025. Given the oversubscription levels and GMP signals, the debut is expected to be strong, though investors should watch market conditions closely.
